Hetero Drugs

Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. The company is recognized for its strengths in research and development, manufacturing and commercialization of a wide range of products. Hetero has 36 manufacturing facilities strategically located worldwide, approved by stringent global regulatory authorities. 300 plus products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology, and Immunology. Hetero has a presence in over 126 countries and focusses on making affordable medicines accessible to patients worldwide.

Hetero Drugs Limited
Type
Public (Government of India)
IndustryPharmaceuticals
Founded1993
HeadquartersHyderabad, India
Key people
Dr BPS Reddy
ProductsPharmaceuticals
Number of employees
Over 21,000
Websitewww.heteroworld.com

Operations

Hetero group employs over 21,000 people. Hetero is a player in the active pharmaceutical ingredients market and finished dosages.[1] It has marketing presence in over 127 countries.

Hetero has supplied antiretroviral drugs to patients across more than 100 countries globally.[2]

Today, Oseltamivir, sold under its brand name Tamiflu, is also indicated for A[H1N1] virus, also known as swine flu.

Hetero also produces hepatitis C antivirals such as Sofovir (sofosbuvir) and Ledifos (a fixed-dose combination of sofosbuvir and ledipasvir).

Company structure

Hetero Drugs Limited is the parent company in the Hetero group of companies and other companies which are part of the group are Hetero Labs, Hetero Research Foundation, Genx Laboratories and also foreign subsidiaries such as Camber Pharma Inc., in USA, Hetero Europe in Europe, and Richmond Labs in Argentina. The group is also investing in the wind power industry with a goal to reach 1000 megawatts by 2017.[3]

2009 flu outbreak

In 2009, as the swine flu outbreak was spreading across the globe and various health organizations and government agencies were piling up stocks of Oseltamivir as precautionary measures, Hetero supplied generic Oseltamivir under its brand name Fluvir.[4]

Hetero delivered 10 million doses of Oseltamivir to the Indian government in 2009,[5] and shipped about 80 million doses to over 60 countries.[6] Hetero received its second order from Indian government to supply another 10 million doses of Oseltamivir later in 2009.[7]

References
  1. "Archived copy". Archived from the original on 16 September 2016. Retrieved 11 July 2016.CS1 maint: archived copy as title (link)
  2. ":: Welcome to Hetero ::". Heterodrugs.com. Archived from the original on 17 January 2014. Retrieved 11 January 2014.
  3. "Hetero Windpower". Hetero. Retrieved 22 June 2018.
  4. Archived 30 April 2009 at the Wayback Machine
  5. Khomba Singh, ET Bureau 5 May 2009, 12.03am IST (5 May 2009). "Hetero bags mega chunk of govt's anti-flu drug deal - Economic Times". Economictimes.indiatimes.com. Retrieved 11 January 2014.CS1 maint: multiple names: authors list (link)
  6. "Hyderabad pharma cos cash in on Swine-Flu fever". Moneycontrol.com. Retrieved 11 January 2014.
  7. Khomba Singh, ET Bureau 22 August 2009, 03.02am IST (22 August 2009). "Hetero bags deal for 10 m Tamiflu - Economic Times". Economictimes.indiatimes.com. Retrieved 11 January 2014.CS1 maint: multiple names: authors list (link)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.